Intuit Downgraded While Intuitive Surgical Upgraded by Wall Street Analysts
Wall Street analysts have issued several notable upgrades and downgrades this week, with UBS leading the charge on medical device stocks. The firm upgraded Intuitive Surgical (ISRG) to Buy from Neutral, citing a potential acceleration in automation adoption for surgical procedures. Edwards Lifesciences (EW), Stryker (SYK), and Zimmer Biomet (ZBH) also received upgrades due to strong growth prospects. On the downside, TD Cowen downgraded Intuit (INTU) to Hold with a significantly reduced price target of $304 from $504. The firm cited limited near-term catalysts for recovery in the stock's value. Other companies like Clorox and RXO Inc also faced downgrades due to soft share performance, leadership changes, or legal risks. Analysts at UBS and JPMorgan highlighted undervalued opportunities such as Becton Dickinson (BDX) and International Paper (IP), while others pointed toward favorable trends in sectors like fertilizers and packaging.
Tickers: $BDX $CLX $DXCM $EW $HON $INTU $ISRG $NTR $RXO $SYK $ZBH